Digital Therapeutics

Selected news for the healthcare topic - Digital Therapeutics, collected since 10/2017. This healthcare topic shares news with Digital Health, Mental Health, DarioHealth, Pear Therapeutics, Biofourmis and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
9/14/2021 Digital Health Market: Top trends boosting the industry expansion through 2027 emrindustry.com ... medical decision-making processes that would alter their way of living in some ways. Patients across the world are getting world-class treatments, thereby improving their overall experience with doctors and other staff members. Digital therapeutics are being increasingly used to increase the efficiency of medical procedures and provide accurate diagnosis to patients. Some of the examples of these therapeutics are insulin pumps, wearable gadgets and blood glucose meters. Venture ...
9/14/2021 Woebot Health Unveils Scientific Advisory Board tmcnet.com ... its Scientific Advisory Board, a group of healthcare and technology leaders whose deep and diverse experience will help advance the company's clinical and research and development activities as it develops the next generation of digital therapeutics that engage people in their mental health. "The formation of our Scientific Advisory Board is a foundational next step as we continue to expand our overall body of research, as well as advance through ...
9/13/2021 CureApp Hypertension Therapeutics App: Clinical Trial Results Announced at ESC Congress 2021 and Published in the European Heart Journal, a Leading Cardiovascular Journal Yahoo News Japan’s first major leap toward digital therapeutics in the field of hypertensionTOKYO, September 13, 2021 --( BUSINESS WIRE )--The results of a Japanese Phase III domestic multicenter randomized controlled trial of a digital therapeutic app for hypertension (DTx) jointly developed by CureApp, Inc. (CEO Kohta Satake; hereafter "the Company") and Jichi Medical University were presented by Professor Kazuomi Kario of Jichi University’s Department of Cardiovascular Medicine at the ...
9/11/2021 Digital Therapeutics Market 2020 Demand with Global Forecast by Top Leading Players: Proteus Digital Health, Omada Health, WellDoc, 2Morrow, Livongo Health, Propeller Health, Twine Health, Canary Health packagingnews24.com ... Players: Proteus Digital Health, Omada Health, WellDoc, 2Morrow, Livongo Health, Propeller Health, Twine Health, Canary Health, New Jersey, United States: A qualitative research study accomplished by Verified Market Research titled 2020-2026 Global and Regional Digital Therapeutics Market: Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report is the most up to date report which comprises the latest trends that influence the market competition in the forecast period ...
9/10/2021 The Role of AI in Digital Therapeutics pharmexec.com ... begin to change healthcare as well.\n\nThe use of AI in healthcare has opened a new world of possibilities and continues to evolve in terms of its capabilities, scope, and scale. For the digital therapeutics industry specifically, where nearly 200 new apps are launched every day, AI plays a significant role in driving personalization and engagement to help patients achieve better health.\n\nPersonalization\n\nWith something as nuanced ...
9/9/2021 Digital Health Ecosystems Part 1: Insurtechs as connectors findaily.pro ... the way for cost-effective data-sharing solutions that enable new ecosystem applications. More enabling regulatory changes are starting to evolve, such as the regulatory framework for telemedicine in Germany, that lets doctors prescribe digital therapeutics backed by system wide electronic health records that were launched beginning of 2021. Business ecosystems are not a panacea and in many scenarios, extant models will perform better. However, ecosystems are the governance model ...
9/9/2021 DarioHealth Chosen by Northeast Regional Employer PR Newswire Dario Continues to Expand its Employer Contracts Across Broad Range of SolutionsNEW YORK , Sept. 9, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO ), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into an agreement to provide its suite of digital therapeutics for diabetes, hypertension and pre-diabetes to a Northeast regional employer ("Employer"). The contract is expected to contribute revenue beginning in the first ...
9/9/2021 DarioHealth Chosen by Northeast Regional Employer PR Newswire Dario Continues to Expand its Employer Contracts Across Broad Range of SolutionsNEW YORK , Sept. 9, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO ), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into an agreement to provide its suite of digital therapeutics for diabetes, hypertension and pre-diabetes to a Northeast regional employer ("Employer"). The contract is expected to contribute revenue beginning in the first ...
9/9/2021 Neuroglee looks to Mayo partnership, digital therapeutics to tackle mild cognitive impairment - MedCity News MedCity News ... don’t repeat the same and help them scale the business,” Kuldeep Singh Rajput said in a Zoom interview.There’s also some overlap between the two businesses. Biofourmis has been working on digital therapeutics for cardiology and oncology, while Neuroglee is taking a similar approach for neurology.To start, Neuroglee will work with Mayo Clinic to co-develop a virtual care platform based on Mayo Clinic’s current ...
9/9/2021 Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions – TechCrunch worldnewsera.com Neuroglee Therapeutics](//neuroglee.com/) , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. The funding will be used to launch virtual neurology clinics and to support Neuroglee’s move to Boston. Other participants included Ramen Singh, the former chief executive officer of Mundipharma; Biofourmis co-founders Kuldeep Singh Rajput and Wendou Liu; and Eisai Co., the Japanese ...
9/9/2021 Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions Yahoo News Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. The funding will be used to launch virtual neurology clinics and to support Neuroglee’s move to Boston. Other participants included Ramen Singh, the former chief executive officer of Mundipharma; Biofourmis co-founders Kuldeep Singh Rajput and Wendou Liu; and Eisai Co., the Japanese pharmaceutical ...
9/9/2021 Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions baillytech.com Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. The funding will be used to launch virtual neurology clinics and to support Neuroglee’s move to Boston. Other participants included Ramen Singh, the former chief executive officer of Mundipharma; Biofourmis co-founders ...
9/9/2021 Neuroglee Therapeutics Closes Series A Round to Advance Virtual Care and Digital Therapies for Alzheimer's Disease Treatment in the Home healthcareittoday.com Neuroglee Therapeutics (‘Neuroglee’), which builds personalized evidence-based digital therapeutics (DTx) and virtual care solutions to treat and manage patients with neurodegenerative diseases, announced today that it has closed a $10 million Series A funding round. The funding injection will enable Neuroglee to launch first-of-their-kind virtual neurology clinics for patients diagnosed with mild cognitive impairment related to difficult-to-treat conditions such as Alzheimer’s disease ...
9/9/2021 Neuroglee Therapeutics Closes Series A Round to Advance Virtual Care and Digital Therapies for Alzheimer's Disease Treatment in the Home salesandmarketingnetwork.com ... virtual specialty care clinic for patients with mild cognitive impairmentCompany will move headquarters to Boston in Q4 2021 BOSTON, Sept. 9, 2021 -- (Healthcare Sales & Marketing Network) -- Neuroglee Therapeutics ('Neuroglee'), which builds personalized evidence-based digital therapeutics (DTx) and virtual care solutions to treat and manage patients with neurodegenerative diseases, announced today that it has closed a $10 million Series A funding round. The funding injection will enable Neuroglee to launch ...
9/9/2021 Neuroglee Therapeutics Closes Series A Round to Advance Virtual Care and Digital Therapies for Alzheimer's Disease Treatment in the Home tncontentexchange.com BOSTON, Sept. 9, 2021 /PRNewswire/ -- Neuroglee Therapeutics ('Neuroglee'), which builds personalized evidence-based digital therapeutics (DTx) and virtual care solutions to treat and manage patients with neurodegenerative diseases, announced today that it has closed a $10 million Series A funding round. The funding injection will enable Neuroglee to launch first-of-their-kind virtual neurology clinics for patients diagnosed with mild cognitive impairment related to difficult-to-treat conditions such ...
9/9/2021 Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions TechCrunch Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. The funding will be used to launch virtual neurology clinics and to support Neuroglee’s move to Boston. Other participants included Ramen Singh, the former chief executive officer of Mundipharma; Biofourmis co-founders Kuldeep Singh Rajput and Wendou Liu; and Eisai Co., the Japanese pharmaceutical ...
9/9/2021 Neuroglee Raises $10M to Develop Virtual Neurology Clinics with Mayo Clinic, Others HIT Consultant What You Should Know: Neuroglee , a Boston, MA-based provider of personalized evidence-based digital therapeutics (DTx) and virtual care solutions, today announced it has raised $10M in Series A funding led by OpenSpace Ventures with participation by EDBI. – Neuroglee Therapeutics discovers, develops and commercializes personalized evidence-based digital therapeutics (DTx) and virtual care solutions to treat and manage patients with neurodegenerative diseases. Neuroglee’s adaptive learning platform uses ...
9/9/2021 Pear and Thimble Point Announce Nominees to Board of Directors | Financial Buzz financialbuzz.com Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing prescription digital therapeutics (“PDTs”) to treat serious disease, and Thimble Point Acquisition Corp. (Nasdaq: THMA) today announced that Kirthiga Reddy and Alison Bauerlein are nominees to become directors of THMA, which will be renamed Pear Holdings Corp. upon the closing of the previously announced business combination of THMA and Pear (the “Business Combination”). Ms. Reddy, Partner at ...
9/8/2021 DarioHealth Selected by Another Employer for Behavioral Health Services techrseries.com DarioHealth Selected by Another Employer for Behavioral Health Services Employee wellnessNews By HRTech News Desk On Sep 8, 2021 Dario Continues Strong Expansion in Employer Market Leveraging Broad Product Platform DarioHealth Corp., a leader in the global digital therapeutics (DTx) market, announced that it has entered into an agreement to provide its digital behavioral health platform to a casino resort company in California. The contract is expected to contribute revenue ...
9/8/2021 DarioHealth Selected by Another Employer for Behavioral Health Services tncontentexchange.com NEW YORK, Sept. 8, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into an agreement to provide its digital behavioral health platform to a casino resort company ("Casino Resort Company") in California. The contract is expected to contribute revenue beginning in the fourth quarter of 2021. The Casino Resort Company selected Dario's digital behavioral health solution to ...